NSE · ABBOTINDIA
Abbott India Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹7,217 Cr with net profit ₹1,552 Cr — a 21.5% net margin, versus 21.16% the period before.
Shareholding
As of 2026-06-30
- Promoter74.99%
- Public15.85%
- FII0.38%
- DII8.78%
78,320 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.26× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pharmaceuticals - Multinational · ranked #1 of 6 by market cap · medians across 5 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Abbott India Limited(this company) | ₹53,676 Cr | 33.24 | 11.25 | 32.51% | 23.05% |
| Glaxosmithkline Pharmaceuticals Ltd. | ₹48,127 Cr | 45.71 | 21.22 | 45.69% | 27.01% |
| Pfizer Ltd. | ₹18,736 Cr | 24.36 | 4.46 | 17.19% | 28.61% |
| Sanofi Consumer Healthcare India Ltd. | ₹9,419 Cr | 35.41 | 27.2 | 76.46% | 28.01% |
| Sanofi India Limited | ₹7,153 Cr | 18.83 | 8.66 | 39.2% | 17.94% |
| Novartis India Ltd. | ₹5,988 Cr | 61.24 | 7.32 | 11.39% | 26.38% |
AI analysis
AI-generated · google/gemini-2.5-flashAbbott India Limited is listed on the Indian markets with a market capitalization of Rs 61198 Cr. The company reported an EPS of 730.36 and a Book Value of 2246.68. The dividend yield was 2.28% and the PE ratio stood at 39.43.
Positives
- +The debt-to-equity ratio is low at 0.02.
- +Return on Capital Employed (ROCE) is high at 42.54%.
- +Promoter holding is stable at 74.9862% as of June 30, 2026.
- +The company has a high profit margin of 22.4%.
Negatives
- −FII holding has decreased from 2.8694% in June 2018 to 0.3796% in June 2026.
- −DII holding has increased from 6.429% in June 2018 to 8.7819% in June 2026, indicating a shift in institutional ownership.
Financial Performance
Abbott India Limited has shown consistent revenue growth over the past few years. Revenue increased from Rs 4390.92 Cr in Mar 2021 to Rs 6684.73 Cr in Mar 2025. Net profit also grew from Rs 690.69 Cr in Mar 2021 to Rs 1414.44 Cr in Mar 2025. Quarterly revenues have been relatively stable, with the most recent quarter (Mar 2026) reporting Rs 1709.51 Cr.
Profitability & Returns
The company maintained a profit margin of 22.4%. Return on Equity (ROE) was 32.51% and Return on Capital Employed (ROCE) was 42.54%. Earnings per share (EPS) have consistently increased, from Rs 325.04 in Mar 2021 to Rs 665.62 in Mar 2025.
Balance Sheet
Abbott India Limited has a low debt-to-equity ratio of 0.02, indicating minimal reliance on debt financing. The book value per share is Rs 2246.68.
Ownership & Pledges
As of June 30, 2026, promoters held 74.9862% of the company's shares. Public shareholding was 15.8523%, FIIs held 0.3796%, and DIIs held 8.7819%. Institutions held a total of 9.1615%. There were no promoter pledges reported.
Data as of — price: 2026-09-11 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.